Lipopolysaccharide (LPS) is a potent bacterial product that has been s
hown to act on many different cell types both in vivo and in vitro, In
jection of immunologically competent mice with LPS results in increase
d serum cytokine levels, followed by an array of pathophysiologic alte
rations that can ultimately lead to death, In this study, we examined
the response of severe combined immunodeficient (SCID) mice to LPS, Th
ese mice lack mature T and B cells and have been shown to be an import
ant model for analyzing the contribution of innate immune responses to
infectious agents, Injection of SCID mice with LPS resulted in increa
ses in CSF, TNF, and IFN levels in serum that were similar to the resp
onses of immunocompetent controls, In response to LPS, both SCID and c
ontrol mice exhibited similar levels of hypoglycemia, LPS-induced toxi
city was assessed in D(+)-galactosamine-sensitized animals, SCID mice
were comparably sensitive to the lethal effects of LPS as control BALB
/c mice. To assess the role of natural killer (NK) cells in LPS-induce
d cytokine responses, BALB/c and SCID mice were injected with anti-asi
alo-GM1 antibody prior to injection of LPS, No significant effect on L
PS-induced CSF or blood glucose levels were seen, although NK-depleted
SCID mice produced somewhat more IFN in response to LPS than normal m
ice. Thus, NK cells are not a major source of these early LPS-induced
cytokines, These data suggest that mature T and B cells and NK cells d
o not contribute to the initial wave of cytokines produced in response
to LPS, but may contribute as secondary producers of cytokines involv
ed in the cytokine cascade elicited by LPS injection.